| SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls N Le Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, ... Nature 584 (7821), 457-462, 2020 | 2031 | 2020 |
| Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients AT Tan, M Linster, CW Tan, N Le Bert, WN Chia, K Kunasegaran, ... Cell reports 34 (6), 2021 | 630 | 2021 |
| Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study WN Chia, F Zhu, SWX Ong, BE Young, SW Fong, N Le Bert, CW Tan, ... The Lancet Microbe 2 (6), e240-e249, 2021 | 368 | 2021 |
| Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 L Swadling, MO Diniz, NM Schmidt, OE Amin, A Chandran, E Shaw, ... Nature 601 (7891), 110-117, 2022 | 327 | 2022 |
| Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection N Le Bert, HE Clapham, AT Tan, WN Chia, CYL Tham, JM Lim, ... Journal of Experimental Medicine 218 (5), e20202617, 2021 | 306 | 2021 |
| PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection L Salimzadeh, N Le Bert, CA Dutertre, US Gill, EW Newell, C Frey, ... The Journal of clinical investigation 128 (10), 4573-4587, 2018 | 234 | 2018 |
| Hepatitis B virus–specific T cells associate with viral control upon nucleos (t) ide-analogue therapy discontinuation L Rivino, N Le Bert, US Gill, K Kunasegaran, Y Cheng, DZM Tan, E Becht, ... The Journal of clinical investigation 128 (2), 668-681, 2018 | 196 | 2018 |
| Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset S Kalimuddin, CYL Tham, M Qui, R de Alwis, JXY Sim, JME Lim, HC Tan, ... Med 2 (6), 682-688. e4, 2021 | 193 | 2021 |
| Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells YJ Shen, N Le Bert, AA Chitre, CXE Koo, XH Nga, SSW Ho, M Khatoo, ... Cell reports 11 (3), 460-473, 2015 | 173 | 2015 |
| Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming AP Bénéchet, G De Simone, P Di Lucia, F Cilenti, G Barbiera, N Le Bert, ... Nature 574 (7777), 200-205, 2019 | 170 | 2019 |
| RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma AR Lam, N Le Bert, SSW Ho, YJ Shen, MLF Tang, GM Xiong, JL Croxford, ... Cancer research 74 (8), 2193-2203, 2014 | 160 | 2014 |
| SARS-CoV-2-specific T cells in infection and vaccination A Bertoletti, N Le Bert, M Qui, AT Tan Cellular & molecular immunology 18 (10), 2307-2312, 2021 | 148 | 2021 |
| Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection N Le Bert, US Gill, M Hong, K Kunasegaran, DZM Tan, R Ahmad, ... Gastroenterology 159 (2), 652-664, 2020 | 123 | 2020 |
| Immunotherapy for chronic hepatitis B virus infection A Bertoletti, N Le Bert Gut and liver 12 (5), 497, 2018 | 120 | 2018 |
| Use of expression profiles of HBV-DNA integrated into genomes of hepatocellular carcinoma cells to select T cells for immunotherapy AT Tan, N Yang, TL Krishnamoorthy, V Oei, A Chua, X Zhao, HS Tan, ... Gastroenterology 156 (6), 1862-1876. e9, 2019 | 112 | 2019 |
| Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals AT Tan, JME Lim, N Le Bert, K Kunasegaran, A Chia, MDC Qui, N Tan, ... The Journal of clinical investigation 131 (17), 2021 | 92 | 2021 |
| Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals D Lozano-Ojalvo, C Camara, E Lopez-Granados, P Nozal, ... Cell reports 36 (8), 2021 | 92 | 2021 |
| SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity JME Lim, AT Tan, N Le Bert, SK Hang, JGH Low, A Bertoletti Journal of Experimental Medicine 219 (10), 2022 | 85 | 2022 |
| SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic A Bertoletti, N Le Bert, AT Tan Immunity 55 (10), 1764-1778, 2022 | 72 | 2022 |
| The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role A Bertoletti, AT Tan, N Le Bert Oxford Open Immunology 2 (1), iqab006, 2021 | 70 | 2021 |
Antonio BertolettiDuke-Nus Medical SchoolVerified email at duke-nus.edu.sg
